Research

Adherence

In primary prevention clinical practice across Europe, less than half of treated hypertensive and dyslipidaemic patients achieve target blood pressure and lipid levels, and only one-third of treated diabetic patients achieve the HbA1c target.

If you are being treated for high blood pressure, high cholesterol, or diabetes, do not assume you are 'safe' just because you are taking medication. The study shows that most people on treatment still do not reach healthy target levels. You must actively engage with your healthcare provider to ensure your numbers are actually within the target range, and prioritize lifestyle changes like diet and exercise, as medication alone is often insufficient.

GoodRefutesHIGH confidence
Among treated hypertensives (94.2%), only 38.8% achieved the blood pressure target of <140/90 mmHg... Among treated dyslipidaemic patients (74.4%), 41.2% attained both the total- and LDL-cholesterol target... Among treated type 2 diabetic patients (87.2%), 36.7% achieved the <6.5% HbA1c target
José R. Banegas et al. · European Heart Journal · 2011

Why this rating

Large-scale cross-sectional observational study (n=7641) across 12 countries with standardized central laboratory testing, though not a randomized controlled trial.

Source

Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study

José R. Banegas et al. · European Heart Journal · 2011

cross_sectional · n=7641Cited 356×
Read the paper

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →